His primary areas of study are Microbiology, Bacteroides, Lactobacillus, Prevotella and Bacteria. His Microbiology research integrates issues from Clostridium, Dysbiosis and Bifidobacterium, Clostridium leptum. He works mostly in the field of Dysbiosis, limiting it down to topics relating to In vivo and, in certain cases, Colitis and Probiotic.
His work focuses on many connections between Clostridium leptum and other disciplines, such as Firmicutes, that overlap with his field of interest in Immunology and Gastroenterology. His Prevotella study which covers Gut flora that intersects with Leptin, Diabetes mellitus, Weight loss and Surgery. Gérard Corthier has included themes like Reporter gene, Lysis and Green fluorescent protein in his Bacteria study.
His scientific interests lie mostly in Microbiology, Lactococcus lactis, Bacteria, Biochemistry and Lactobacillus. His Microbiology research is multidisciplinary, relying on both Lactobacillus casei, Bacteroides, Probiotic and Lactic acid. His work is dedicated to discovering how Bacteroides, Clostridium are connected with Human microbiome and other disciplines.
The concepts of his Lactococcus lactis study are interwoven with issues in Extracellular, Heterologous, Immune system and Signal peptide. While the research belongs to areas of Bacteria, Gérard Corthier spends his time largely on the problem of Luciferase, intersecting his research to questions surrounding Cecum. In his study, Immunology, Inflammatory bowel disease and Dysbiosis is strongly linked to Firmicutes, which falls under the umbrella field of Clostridium leptum.
The scientist’s investigation covers issues in Microbiology, Lactobacillus, Immunology, Immunoglobulin E and Prevotella. His Microbiology study integrates concerns from other disciplines, such as Lactobacillus casei, Dysbiosis, Intestinal mucosa and Clostridium leptum. His studies in Lactobacillus integrate themes in fields like Phenotype, Genome and Lactic acid.
In the subject of general Immunology, his work in BALB/c and Immunogenicity is often linked to Beta-lactoglobulin, thereby combining diverse domains of study. His Prevotella research incorporates elements of Gut flora, Food science, Bacteroides, Host and Metabolic pathway. His study explores the link between Inflammatory bowel disease and topics such as Faecalibacterium prausnitzii that cross with problems in Firmicutes.
His primary scientific interests are in Microbiology, Prevotella, Lactobacillus, Faecalibacterium prausnitzii and Clostridium leptum. His work carried out in the field of Microbiology brings together such families of science as Metabolic pathway and Bacteroides. As a part of the same scientific study, Gérard Corthier usually deals with the Prevotella, concentrating on Gut flora and frequently concerns with Obesity, Surgery, Weight loss, Diabetes mellitus and Leptin.
His Faecalibacterium prausnitzii research is multidisciplinary, incorporating perspectives in Gastroenterology, Colitis and Inflammatory bowel disease. The study incorporates disciplines such as Clostridium, Human microbiome and Firmicutes in addition to Clostridium leptum. His work deals with themes such as Infectious Colitis, Ulcerative colitis, Immunology, Internal medicine and Crohn's disease, which intersect with Firmicutes.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
Harry Sokol;Bénédicte Pigneur;Laurie Watterlot;Omar Lakhdari.
Proceedings of the National Academy of Sciences of the United States of America (2008)
The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age.
Denis Mariat;Olivier Firmesse;Florence Levenez;Vd Guimarăes.
BMC Microbiology (2009)
Low counts of Faecalibacterium prausnitzii in colitis microbiota.
Sokol H;Seksik P;Furet Jp;Firmesse O.
Inflammatory Bowel Diseases (2009)
Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers.
Jean-Pierre Furet;Ling-Chun Kong;Julien Tap;Christine Poitou.
Microbial dysbiosis in colorectal cancer (CRC) patients.
Iradj Sobhani;Julien Tap;Françoise Roudot-Thoraval;Jean P. Roperch.
PLOS ONE (2011)
Comparative study of bacterial groups within the human cecal and fecal microbiota.
Philippe Marteau;Philippe Marteau;Philippe Pochart;Philippe Pochart;Joël Doré;Christel Béra-Maillet.
Applied and Environmental Microbiology (2001)
Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR.
Jean-Pierre Furet;Olivier Firmesse;Michèle Gourmelon;Chantal Bridonneau.
FEMS Microbiology Ecology (2009)
Should yoghurt cultures be considered probiotic
Francisco Guarner;Gabriela del Valle Perdigon;Gérard Corthier;Seppo Salminen.
British Journal of Nutrition (2005)
Survival, physiology, and lysis of Lactococcus lactis in the digestive tract.
Sophie Drouault;Gérard Corthier;S. Dusko Ehrlich;Pierre Renault.
Applied and Environmental Microbiology (1999)
Gut microbiota richness promotes its stability upon increased dietary fibre intake in healthy adults.
Julien Tap;Jean-Pierre Furet;Martine Bensaada;Catherine Philippe.
Environmental Microbiology (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: